Tranexamic acid for traumatic brain injury: A systematic review and meta-analysis

American Journal of Emergency Medicine

Volumn 32, Issue 12, 2014, Pages 1503-1509

  Zehtabchi, Shahriar ^a   Abdel Baki, Samah G ^a   Falzon, Louise ^b   Nishijima, Daniel K ^c  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b Department of Medicine   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ARTICLE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CINAHL; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG QUALITY; EMBASE; FUNCTIONAL STATUS; HUMAN; MEDLINE; META ANALYSIS; MORTALITY; MULTICENTER STUDY (TOPIC); NERVOUS SYSTEM FUNCTION; OUTCOME ASSESSMENT; PATIENT RISK; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; TRAUMATIC BRAIN INJURY; VENOUS THROMBOEMBOLISM; BRAIN INJURIES; INTRACRANIAL HEMORRHAGES;

ANTIFIBRINOLYTIC AGENTS; BRAIN INJURIES; HUMANS; INTRACRANIAL HEMORRHAGES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRANEXAMIC ACID;

EID: 84917683344     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2014.09.023     Document Type: Article

References (26)

1. M. Faul, L. Xu, M.M. Wald, and V.G. Coronado Traumatic brain injury in the United States: emergency department visits, hospitalizations, and deaths 2010 Centers for Disease Control and Prevention, National Center for Injury Prevention and Control Atlanta (GA)
2. G.L. Olin, and J.A. Rhoades The five most costly medical conditions, 1997 and 2002: estimates for the U.S. civilian noninstitutionalized populations AHRQ 2006 [Rockville, MD]. Available at: http://meps.ahrq.gov/mepsweb/data-files/publications/st80/stat80.shtml. Last accessed Octber 6, 2014
3. S.R. Shackford, R.C. Mackersie, J.W. Davis, P.L. Wolf, and D.B. Hoyt Epidemiology and pathology of traumatic deaths occurring at a level I trauma center in a regionalized system: the importance of secondary brain injury J Trauma 29 1989 1392 1397
4. R.K. Narayan, A.I. Maas, F. Servadei, B.E. Skolnick, M.N. Tillinger, and L.F. Marshall Progression of traumatic intracerebral hemorrhage: a prospective observational study J Neurotrauma 25 2008 629 639
5. D.I. Graham, I. Ford, J.H. Adams, D. Doyle, G.M. Teasdale, and A.E. Lawrence Ischaemic brain damage is still common in fatal non-missile head injury J Neurol Neurosurg Psychiatry 52 1989 346 350
6. L.F. Marshall, T. Gautille, and M.R. Klauber The outcome of severe closed head injury J Neurosurg 75 1991 S28 S36
7. B.S. Harhangi, E.J. Kompanje, F.W. Leebeek, and A.I. Maas Coagulation disorders after traumatic brain injury Acta Neurochir (Wien) 150 2008 165 175
8. P. Talving, R. Benfield, P. Hadjizacharia, K. Inaba, L.S. Chan, and D. Demetriades Coagulopathy in severe traumatic brain injury: a prospective study J Trauma 66 2009 55 61
9. CRASH-2 Trial Collaborators Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial Lancet 376 2010 23 32
10. I. Roberts, H. Shakur, K. Ker, T. Coats CRASH-2 Trial collaborators Antifibrinolytic drugs for acute traumatic injury Cochrane Database Syst Rev 12 2012 1 23 [CD004896]
11. C. Guerriero, J. Cairns, P. Perel, H. Shakur, I. Roberts CRASH 2 trial collaborators Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial PLoS One 6 2011 1 6 [e18987]
12. Available at http://www.prisma-statement.org [Last accessed April 17, 2014]
13. CRASH-2 Collaborators Intracranial Bleeding Study Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study) BMJ 343 2011 354 365
14. S. Yutthakasemsunt, W. Kittiwatanagul, P. Piyavechvirat, B. Thinkamrop, N. Phuenpathom, and P. Lumbiganon Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial BMC Emerg Med 13 2013 20 27
15. Y. Dewan, E.O. Komolafe, J.H. Mejía-Mantilla, P. Perel, I. Roberts, and H. Shakur CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial Trials 13 2012 87 101
16. G.H. Guyatt, A.D. Oxman, G. Vist, R. Kunz, J. Brozek, and P. Alonso-Coello GRADE guidelines: 4. Rating the quality of evidence - study limitations (risk of bias) J Clin Epidemiol 64 2011 407 415
17. M.M. Carrick, A.H. Tyroch, C.A. Youens, and T. Handley Subsequent development of thrombocytopenia and coagulopathy in moderate and severe head injury: support for serial laboratory examination J Trauma 58 2005 725 729
18. J.D. Olson, H.H. Kaufman, J. Moake, T.W. O'Gorman, K. Hoots, and K. Wagner The incidence and significance of hemostatic abnormalities in patients with head injuries Neurosurgery 24 1989 825 832
19. H.H. Kaufman, K.S. Hui, J.C. Mattson, A. Borit, T.L. Childs, and W.K. Hoots Clinicopathological correlations of disseminated intravascular coagulation in patients with head injury Neurosurgery 15 1984 34 42
20. S.C. Stein, and D.H. Smith Coagulopathy in traumatic brain injury Neurocrit Care 1 2004 479 488
21. A. Bayir, E. Kalkan, S. Koçak, A. Ak, B. Cander, and S. Bodur Fibrinolytic markers and neurologic outcome in traumatic brain injury Neurol India 54 2006 363 365
22. B.E. Figueroa, R.F. Keep, A.L. Betz, and J.T. Hoff Plasminogen activators potentiate thrombin-induced brain injury Stroke 29 1998 1202 1207
23. D. Dowlatshahi, A.M. Demchuk, M.L. Flaherty, M. Ali, P.L. Lyden, and E.E. Smith Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes Neurology 76 2011 1238 1244
24. T.R. Fleming, and D.L. DeMets Surrogate end points in clinical trials: are we being misled? Ann Intern Med 125 1996 605 613
25. S.A. Mayer, N.C. Brun, K. Begtrup, J. Broderick, S. Davis, and M.N. Diringer Recombinant activated factor VII for acute intracerebral hemorrhage N Engl J Med 352 2005 777 785
26. S.A. Mayer, N.C. Brun, K. Begtrup, J. Broderick, S. Davis, and M.N. Diringer Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage N Engl J Med 358 2008 2127 2137